Guerbet announces the acquisition of a new microsphere technology to strengthen its interventional imaging range

• Acquisition of a technology developed by Occlugel, a French company specialized in the R&D of microspheres used in embolization;

• This new technology will round out Guerbet’s Interventional Imaging solutions and create synergies with the Accurate range of anti-reflux microcatheters.

We use cookies to improve your website experience and to gain insights into our websites’ users and traffic to make it even better. By continuing your navigation on our site without modifying the setting of your cookies, you accept the use of cookies. OKFind out more